Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: MeBIO
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/500mg
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

Related CAS#:

667463-95-8

667463-95-8 structure
667463-95-8 structure
  • Name: MeBIO
  • Chemical Name: 6-bromo-3-[3-(hydroxyamino)indol-2-ylidene]-1-methylindol-2-one
  • CAS Number: 667463-95-8
  • Molecular Formula: C17H12BrN3O2
  • Molecular Weight: 370.20
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage CDK
  • Create Date: 2016-02-10 14:42:16
  • Modify Date: 2024-01-25 00:31:13
  • MeBIO is a potent AhR (aryl hydrocarbon receptor) agonist, with IC50 of 44 μM (GSK-3) and 55 μM (CDK1/cyclin B), respectively. MeBIO is inactive on GSK-3β[1].

Name 6-bromo-3-[3-(hydroxyamino)indol-2-ylidene]-1-methylindol-2-one
Synonyms methyl-6BIO
6-bromo-1-methylindirubin-3'-oxime
IN1310
Description MeBIO is a potent AhR (aryl hydrocarbon receptor) agonist, with IC50 of 44 μM (GSK-3) and 55 μM (CDK1/cyclin B), respectively. MeBIO is inactive on GSK-3β[1].
Related Catalog
Target

GSK-3:44 μM (IC50)

Cdk1/cyclin B:55 μM (IC50)

Cdk5/p25:>100 μM (IC50)

References

[1]. Meijer L, et al. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol. 2003 Dec;10(12):1255-66.

Molecular Formula C17H12BrN3O2
Molecular Weight 370.20
Exact Mass 369.01100
PSA 64.93000
LogP 1.44850
Storage condition -20°C

~%

667463-95-8 structure

667463-95-8

Literature: Polychronopoulos, Panagiotis; Magiatis, Prokopios; Skaltsounis, Alexios-Leandros; Myrianthopoulos, Vassilios; Mikros, Emmanuel; Tarricone, Aldo; Musacchio, Andrea; Roe, S. Mark; Pearl, Laurence; Leost, Maryse; Greengard, Paul; Meijer, Laurent Journal of Medicinal Chemistry, 2004 , vol. 47, # 4 p. 935 - 946

~%

667463-95-8 structure

667463-95-8

Literature: Polychronopoulos, Panagiotis; Magiatis, Prokopios; Skaltsounis, Alexios-Leandros; Myrianthopoulos, Vassilios; Mikros, Emmanuel; Tarricone, Aldo; Musacchio, Andrea; Roe, S. Mark; Pearl, Laurence; Leost, Maryse; Greengard, Paul; Meijer, Laurent Journal of Medicinal Chemistry, 2004 , vol. 47, # 4 p. 935 - 946

~%

667463-95-8 structure

667463-95-8

Literature: Polychronopoulos, Panagiotis; Magiatis, Prokopios; Skaltsounis, Alexios-Leandros; Myrianthopoulos, Vassilios; Mikros, Emmanuel; Tarricone, Aldo; Musacchio, Andrea; Roe, S. Mark; Pearl, Laurence; Leost, Maryse; Greengard, Paul; Meijer, Laurent Journal of Medicinal Chemistry, 2004 , vol. 47, # 4 p. 935 - 946

~%

667463-95-8 structure

667463-95-8

Literature: Polychronopoulos, Panagiotis; Magiatis, Prokopios; Skaltsounis, Alexios-Leandros; Myrianthopoulos, Vassilios; Mikros, Emmanuel; Tarricone, Aldo; Musacchio, Andrea; Roe, S. Mark; Pearl, Laurence; Leost, Maryse; Greengard, Paul; Meijer, Laurent Journal of Medicinal Chemistry, 2004 , vol. 47, # 4 p. 935 - 946

~%

667463-95-8 structure

667463-95-8

Literature: Polychronopoulos, Panagiotis; Magiatis, Prokopios; Skaltsounis, Alexios-Leandros; Myrianthopoulos, Vassilios; Mikros, Emmanuel; Tarricone, Aldo; Musacchio, Andrea; Roe, S. Mark; Pearl, Laurence; Leost, Maryse; Greengard, Paul; Meijer, Laurent Journal of Medicinal Chemistry, 2004 , vol. 47, # 4 p. 935 - 946